1.870USD+6.18%Mkt Cap: 8.13M USDP/E: —Last update: 2026-06-01
PMGC Holdings Inc., a biopharmaceutical company, focuses on the development and acquisition of aesthetic medicines and therapeutic products. It operates through three segments: corporate, treasury and biosciences; IT pac…
Industry Peers
Biotechnology111.39BUSDP/E 26.0
100.62BDKKP/E 19.4
62.97BUSDP/E 14.7
48.39BEURP/E 31.7
44.65BEURP/E 37.2
40.10BUSDP/E 75.3
35.22BUSD—
32.91BSEKP/E 48.6
Indicators:|
Key Statistics
Company
Market Cap8.13M USD
Enterprise Value789.60K USD
Revenue (TTM)1.27M USD
Gross Profit185.31K USD
Net Income (TTM)-7.75M USD
Revenue/Share9.796 USD
Last Price1.870 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees32
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA-0.09
EV/Revenue0.62
P/S6.32
P/B0.27
EPS (TTM)-150.06
EPS (Forward)—
52W Range
1.6200% of range309.89
52W High309.89 USD
52W Low1.620 USD
Profitability
Gross Margin31.40%
Oper. Margin-484.68%
EBITDA Margin0.00%
Profit Margin-1313.00%
ROE-98.86%
ROA-60.21%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-5.93M USD
CapEx (TTM)448.25K USD
FCF Margin-188.97%
FCF Yield-29.55%
Net Debt-7.25M USD
Net Debt/EBITDA0.80
Balance Sheet
Debt/Equity0.34
Current Ratio1.45
Quick Ratio1.39
Book Value/Sh6.509 USD
Cash/Share3.348 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:6
Split DateMar 10, 2026
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.4.54M
Float4.54M
Insiders9.99%
Institutions1.57%
Short Interest
Short Ratio0.3d
Short % Float8.48%
Short % Out.8.48%
Shares Short385.40K
Short (prev mo.)414.51K
Technical
SMA 503.162 (-40.9%)
SMA 20067.00 (-97.2%)
Beta-0.28
S&P 52W Chg27.94%
Avg Vol (30d)993.11K
Avg Vol (10d)1.44M
Technical Indicators
RSI (14)38.8
MACD-0.4697
MACD Signal-0.5716
MACD Hist.+0.1019
BB Upper2.412 USD
BB Middle1.949 USD
BB Lower1.486 USD
BB Width47.47%
ATR (14)0.3733 USD
Vol Ratio (20d)3.14x